AlzeCure Pharma: AlzeCure Gets Two NeuroRestore Abstracts Accepted to Alzheimer's Conference

STOCKHOLM, SWEDEN / ACCESSWIRE / March 22, 2022 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6)AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of small molecule

Related Keywords

Sweden ,Stockholm ,Swedish ,Pontus Forsell ,Cristina Parrado Fern ,Alzecure Pharma ,Johan Sandin ,Neurotrophin Trk ,Swedish Meeting For Alzheimer Research ,Swedish Meeting ,Alzheimer Research ,Results From ,Single Ascending Dose Study ,Healthy Volunteers ,Positive Modulator ,Neurotrophin Trk Receptors ,Nasdaq First North Premier Growth Market ,Nerve Growth Factor ,Brain Derived Neurotrophic Factor ,Alzecure ,Dharma ,Jets ,Neurorestore ,Abstracts ,Accepted ,Lzheimer ,Conference ,